Lv3
324 积分 2025-02-26 加入
Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC
3个月前
已完结
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
3个月前
已完结
The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
3个月前
已完结
Neoadjuvant immunotherapy in resectable hepatocellular carcinoma: A meta-analysis of the current evidence
3个月前
已完结
Compensatory Hypertrophy and Changes of Liver Function After Sequential Transarterial Chemoembolization, Stereotactic Body Radiation Therapy, and Immunotherapy (START-FIT) in Unresectable Hepatocellular Carcinoma
3个月前
已关闭
Surgery for Hepatocellular Carcinoma With Macroscopic Vascular Invasion in the Era of Modern Molecular Therapy
3个月前
已完结
Sintilimab plus lenvatinib in combination with transarterial chemoembolization and subsequent radiofrequency ablation for unresectable hepatocellular carcinoma: a single-arm, single-center study
3个月前
已完结
Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies
3个月前
已完结
Two hepatectomy cases for initially unresectable hepatocellular carcinoma after achieving a radiological complete response to sequential therapy with lenvatinib and transcatheter arterial chemoembolization
3个月前
已完结
Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma
3个月前
已完结
皖公网安备34019202002308
